re: Ann: MESOBLAST PROVIDES UPDATE ON CLINICA... the American market is certainly different to the ASX.$52 wow!My take on Mesoblast is that after the phase 2 results in nov 2011 for (chf) which were good results everything went quiet.I think Teva was wanting more evidence and that another heart study (225 patient trial stem cells injected after a heart attack and a stent inserted) being undertaken by Mesoblast would have been recruiting at that time in Europe.I think Teva got a snippet last year and thats why Mesoblast got the go ahead from Teva to file for the phase 3 trial with the fda.Correct me if Iam wrong about this.There are bout 20 companies involved in stem cell research its not like a single medicine that's had good results in phase 2 and then terrible results in phase 3.This product actually works.
re: Ann: MESOBLAST PROVIDES UPDATE ON CLINICA... the American...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |